Clinical Trials Logo

Filter by:
NCT ID: NCT04821869 Completed - COPD Clinical Trials

ProAir Digihaler in COPD Disease Management: A Real World Study

Start date: May 10, 2021
Phase:
Study type: Observational

A pilot study to explore the utilization of the TEVA ProAir Digihaler rescue medication use and inhalation parameters to identify disease deterioration to help in the management of COPD patients in clinical practice. The study is designed to follow a small sample size of patients with COPD, monitor and collect inhalation parameters from the Digihaler dashboard, and changes in symptom control as measured by the COPD Assessment Test (CAT) to identify potential inhalation parameter thresholds that could be applied to the management of patients with COPD in clinical practice.

NCT ID: NCT04821648 Completed - Submental Fat (SMF) Clinical Trials

RJV001 Study in Adults Receiving Abdominoplasty

Start date: April 16, 2021
Phase: Phase 1
Study type: Interventional

In this study, we are testing a new drug against submental fat (SMF), which is characterized with the accumulation of fat under the chin that often appears as a "double chin". The 2018 American Society for Dermatologic Surgery Consumer Survey on Cosmetic Dermatologic Procedures indicated that 73% of respondents were bothered by "excess fat under the chin/neck". This condition of loose or sagging skin under the chin may affect facial symmetry and attractiveness, which can lead to social embarrassment and a negative self-image in many patients. There is an insufficiency in effective drugs against SMF and double chin. Although an injectable small molecule can be used for improvement of double chin, but its side effects are evident and its cost is high. As such, there remains a real need to develop a cost-effective method to improve appearance of SMF and double chin.

NCT ID: NCT04821557 Completed - Protein Metabolism Clinical Trials

Effect of Microbial Protease Supplementation on Postprandial Amino Acid Levels

Start date: March 30, 2021
Phase: N/A
Study type: Interventional

Dietary protein is digested in the stomach and intestines to smaller peptides and 20 individual amino acids which, when absorbed by the gut into circulation and taken up by skeletal muscle, help stimulate muscle protein synthesis (MPS). Amino acids also provide the building blocks for muscle proteins that contribute to lean mass gains and increased strength following resistance exercise. Therefore, strategies to efficiently maximize amino acid exposure without overconsumption are warranted. Oral enzyme supplementation is a candidate approach to optimize amino acid absorption from dietary protein and protein supplements. Microbial proteases, approved for dietary supplement use, can theoretically speed up the conversion of protein and peptides to amino acids. Protease supplements have been marketed to promote muscle strength by optimizing amino acid absorption, however the clinical evidence is limited. This work will support that ingestion of protease supplements with a meal can allow individuals to more efficiently increase amino acid levels from a given amount of dietary protein.

NCT ID: NCT04821401 Completed - Aging Well Clinical Trials

Rejuvantâ„¢ Safety and Biomarker Study

Start date: February 7, 2020
Phase: N/A
Study type: Interventional

In this randomized, double-blind, placebo-controlled trial in adult men ages 45-65 years and postmenopausal women to age 75 years, the anti-inflammatory property of proprietary CaAKG based dietary supplements will be assessed by the measurement of C-reactive protein (CRP) as the primary endpoint. Secondary safety endpoints will be assessed by monitoring blood chemistry results and recorded adverse effects. In addition, the biological age of the participants will be determined by the level of DNA methylation measured from saliva samples. An open label Sub-Study was conducted on eligible and consenting subjects who were assigned to the placebo. Assessments and endpoints remained the same as for the main study.

NCT ID: NCT04821297 Completed - Cervical Carcinoma Clinical Trials

Linguistically-Tailored Mobile Intervention for the Improvement of Follow Up for Abnormal Pap Test Results

Start date: February 18, 2021
Phase: N/A
Study type: Interventional

This clinical trial evaluates the feasibility of a linguistically-tailored mobile intervention, called CervixChat in improving the follow-up of patients with abnormal Papanicolaou (pap) test results. A text messaging program, such as CervixChat may support patients who need a colposcopy.

NCT ID: NCT04821245 Completed - Clinical trials for Local Anesthetic Complication

Defining Normal Postoperative Magnetic Resonance Imaging After Total Knee Arthroplasty

Start date: December 4, 2018
Phase:
Study type: Observational

The aim of this study was to describe the postoperative "baseline" magnetic resonance imaging (MRI) appearance of the ipsilateral thigh musculature after total knee arthroplasty (TKA). The secondary aim was to describe baseline muscle enzyme levels under the same clinical scenario. Neither of these measures have been reported previously.

NCT ID: NCT04820855 Completed - Clinical trials for Interstitial Cystitis

Mindfulness and Yoga for Pain With Interstitial Cystitis Evaluation

MYPAICE
Start date: May 18, 2021
Phase: N/A
Study type: Interventional

This study is examining impact of pain on daily life, the ability to function and treatments used for patients with interstitial cystitis/painful bladder syndrome before and after a program of mindfulness and yoga, in comparison to patients who are undergoing treatment with their providers.

NCT ID: NCT04820829 Completed - Clinical trials for Cardiovascular Risk Factor

Effects of Proportioning Meat and Plant-based Protein-rich Foods on Cardiovascular Disease Risk Factors (S58)

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

This project will assess the effects of consuming different proportions of red meat (RM) and plant-based, protein-rich foods (nuts, seeds, and soy products - NSS) incorporated into a U.S. Healthy Eating Pattern (HEP) on cardiovascular disease risk factors in adults at high risk of developing a heart-related disease.

NCT ID: NCT04820673 Completed - Acne Vulgaris Clinical Trials

Patient-reported Outcomes for Sarecycline Effectiveness and Safety (PROSES)

PROSES
Start date: May 24, 2021
Phase:
Study type: Observational

The purpose of this study is to evaluate the patient-reported outcomes (PROs) in terms of health-related quality of life (HRQoL) and signs of Acne Vulgaris (AV) among patients with moderate to severe non-nodular AV who are administered sarecycline (Seysara®) in real-world community practice settings in the United States (U.S). Investigator's Global Assessment (IGA) of AV and safety measures associated with use of sarecycline (Seysara®) will be assessed over the study observation period of 12 weeks. Clinicians will prescribe sarecycline (Seyara®) as per their own clinical judgment and standard practice.

NCT ID: NCT04820647 Completed - Clinical trials for Autism Spectrum Disorder

KF STRIDE to Improve Job Interview Skills

Start date: March 29, 2021
Phase: N/A
Study type: Interventional

The goals of the current study are to evaluate the preliminary effectiveness and feasibility of Kessler Foundation-Strength Identification and Expression (KF-STRIDE) in an 8-week randomized controlled trial comparing the intervention to services as usual (SAU).